Skip to content
Abierto

Special notice

LAB - INFECTIOUS DISEASE RETROVIRUS TRANSPLANT AND METABOLIC TESTING

36C24225Q0519

Department of Veterans Affairs, 242-Network Contract Office 02. Analytical Laboratory Instrument Manufacturing.

Awarded

Abbott Laboratories Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov.

The Department of Veterans Affairs, James J. Peters Veterans Affairs Medical Center (VISN 2 South), intends to award a sole-source, firm fixed-price, five-year FSS BPA (FSS-DO) to Abbott Laboratories, Inc., FSS Contract #36F79719D0024, in accordance with FAR Subpart 8.405-6. The acquisition sought is an FSS-BPA that will cover consumables and supplies needed to produce a cost-per-reportable result (CPRR) at the James J. Peters Veterans Affairs Medical Center, and New York Harbor Healthcare System.

VA personnel utilize the equipment and consumables to perform in-house testing of immunosuppressants including, but not limited to, HIV Ag/Ab p-24, Tacrolimus, Sirolimus, Cyclosporine, Syphilis, Hemoglobin A1c, Estradiol, Anti -TG. The NAICS is 334516 with a small business size standard of 1,000 employees. James J. Peters Veterans Affairs Medical Center (JJP VAMC) Pathology & Laboratory Medicine Service, VISN 2 South, requires automated single platform immunoassay analyzers to perform a comprehensive menu of tests.

Two (2) identical single platform analyzers are required due to staffing deficits, space availability, and cost savings/avoidance. The sensitivity and specificity of each assay should yield at least a 95% confidence interval. The selected analyzers will be used for Hepatitis testing, HIV, BNP (B-type Natriuretic Peptides), PCT (Brahms Procalcitonin), Tacrolimus, Cyclosporine, and Sirolimus testing and SARS Covid IgG SARS Covid IgG II.

VA Harbor Healthcare System, Pathology & Laboratory Medicine Service, VISN 2 South, requires a one-year Cost Per Reportable Result (CPRR) contract to perform the comprehensive menu of tests including Hepatitis, HIV, and Tacrolimus. Testing will be performed on analyzers already in place in the VAHHS Laboratory. The current FSS-BPA with Abbott Laboratories, Inc. will expire on July 31, 2025. This notice of intent is not a request for competitive proposals and no solicitation will be made available.

Any responses received no later than COB April 17, 2025 will be considered for the purposes of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
NH3LDK8CFAK7
CAGE
33110
Vendor location
North Chicago, IL
Contract
36C24225A0048 under 36F79719D0024
Obligated
$0.00, potential $1,652,117
Actions
3 between July 31, 2025 and August 1, 2026
Competition
Full and Open Competition, 1 offer received
Described as
Infectious Disease Lab Testing Analyzers and Reagents
Match
award number 36C24225A0048 equals the contract number; same awarding office 36C242 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. April 4, 2025

    Special notice

    Due April 17, 2025 at 3:00 PM EDT. SAM.gov, notice a03eb11d214d474ba05e7e6e57140815

  2. August 7, 2025

    Award notice, originally special notice

    LAB - INFECTIOUS DISEASE RETROVIRUS TRANSPLANT AND METABOLIC TESTING - CPRR

    Awarded to Abbott Laboratories Inc. Abbott Park 60064 for $0. SAM.gov, notice 974a03e12e1c4ba78f99f369492cb809

  3. August 7, 2025

    Special notice

    Due April 17, 2025 at 3:00 PM EDT. SAM.gov, notice d848ce6f327b414a9220278d5b61c4c6

Points of contact